Results 151 to 160 of about 1,428 (167)

IDF2022-0558 A prospective observational study of tofogliflozin in Japan: AYUMI

Diabetes Research and Clinical Practice, 2023
Y. Yamada, K. Shide, A. Suzuki, Y. Terauchi, D. Yabe, N. Shihara, Y. Seino   +6 more
openaire   +1 more source

Tofogliflozin

Reactions Weekly, 2019
openaire   +1 more source

Luseogliflozin/tofogliflozin

Reactions Weekly, 2015
openaire   +1 more source

Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring

Diabetes Therapy, 2020
Yuji Kawaguchi, Yasuro Kumeda
exaly  

Synthesis of Tofogliflozin

Synfacts, 2016
openaire   +1 more source

Clinical course after discontinuation of the SGLT2 inhibitor tofogliflozin

Diabetes Research and Clinical Practice, 2016
Yukio Ikeda, Naoko Hisakawa
openaire   +1 more source

Synthesis of Tofogliflozin Hydrate

Synfacts, 2016
openaire   +1 more source

Development and validation of an LC–MS/MS method for the determination of tofogliflozin in plasma and its application to a pharmacokinetic study in rats

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2016
Shinji Kobuchi
exaly  

Synthesis of Tofogliflozin

Synfacts, 2019
openaire   +1 more source

PEMAFIBRATE AND/OR TOFOGLIFLOZIN FOR USE IN TREATING LIVER DISEASE

2022
KANETA NOBORU, OSHIMA RYU, PENDSE SHONA SANCHITA, TANIGAWA RYOHEI   +3 more
openaire   +2 more sources